What really happens when patients stop GLP-1s like semaglutide or tirzepatide
Whether your goal is modest weight loss or a significant change, your plan is personalized to your health profile, monitored over time, and designed to fit into real life without guesswork
This takes thirty seconds and provides a safety check that catches errors before they become adverse events
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohns disease
To assess the associations of semaglutide with recurrent AUD, the study population comprised 22,113 patients who had active medical encounters for T2DM diagnosis in 12/20175/2021, were for the first time prescribed semaglutide or non-GLP1-1RA anti-diabetes medications during 12/20175/2021(index event), had a diagnosis of AUD on or before the index event, and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event